A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials
NCT01337479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1097
Last updated 2011-04-19
Summary
The purpose of this study is to follow patients treated in entecavir Phase III and rollover studies for safety experience and Hepatitis B virus (HBV)-related complications.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-02-28
- Primary Completion
- 2010-09-30
- Completion
- 2010-09-30
More Related Trials
-
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
NCT00704106 ·Status: COMPLETED
-
A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection
NCT00605384 ·Status: TERMINATED ·Phase: PHASE3
-
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection
NCT00393484 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
NCT00423891 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy
NCT01037166 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation
NCT00065507 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection
NCT00096785 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)
NCT03577171 ·Status: COMPLETED ·Phase: PHASE2
-
Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients
NCT01356901 ·Status: COMPLETED
-
An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B
NCT00124241 ·Status: COMPLETED ·Phase: PHASE2
-
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B
NCT00531167 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection
NCT01079806 ·Status: COMPLETED ·Phase: PHASE3
-
Continue Entecavir Rollover From China
NCT00975091 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
NCT00388674 ·Status: COMPLETED
-
Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)
NCT01155427 ·Status: COMPLETED
-
A Phase II Dose Response Study in Japan in Chronic Hepatitis B
NCT01022801 ·Status: COMPLETED ·Phase: PHASE2
-
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
NCT00467545 ·Status: COMPLETED ·Phase: PHASE4
-
Entecavir for Chronic Hepatitis B
NCT01323452 ·Status: COMPLETED
-
Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load
NCT01013272 ·Status: COMPLETED ·Phase: NA
-
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
NCT00395018 ·Status: COMPLETED ·Phase: PHASE3
-
Lamivudine and Adefovir to Treat Chronic Hepatitis B
NCT00023309 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
NCT01204762 ·Status: COMPLETED ·Phase: PHASE2
-
Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT
NCT01833611 ·Status: UNKNOWN ·Phase: PHASE4
-
Long-Term Lamivudine Therapy for Chronic Hepatitis B
NCT00120354 ·Status: COMPLETED ·Phase: PHASE4
-
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
NCT00662545 ·Status: COMPLETED ·Phase: PHASE4